The collaboration with Galvani provides SHAI with access to global leaders in biotechnology and medicine, enabling further scalability and integration of its solutions. The project represents a significant step in SHAI’s growth and paves the way for deeper engagement with international corporations.

SHAI focuses on enhancing transparency, efficiency, and decision-making through artificial intelligence. Under the agreement, Galvani will implement SHAI’s flagship solution, Compliance AI—a secure, enterprise-level system that mitigates risks, streamlines business processes, and operates within a closed corporate environment to prevent data leaks.

“For us, this agreement is not just a major step forward—it’s global recognition of our technology’s potential. The negotiations lasted several weeks and involved rigorous alignment on data security and confidentiality, which is especially critical in healthcare. We’re proud to have convinced industry giants of the value of our solutions. I’m confident this project will serve as a strong foundation for future international expansion,” said Alibek Polatov, CEO and Co-Founder of SHAI.

SHAI develops enterprise AI assistants trained on internal company data to solve mission-critical tasks and deliver intelligent support across healthcare, pharmaceuticals, biotechnology, and industrial sectors. Since late 2024, the team has successfully delivered over ten projects across Kazakhstan and beyond, in the public sector, industry, and education.

A key differentiator of SHAI is its end-to-end deployment support: the team trains client staff to effectively interact with AI agents, ensuring seamless adoption. The platform is securely deployed within a closed corporate network, fully tailored to the client’s business needs, and eliminates AI “hallucinations” by relying exclusively on verified internal data.